Ab Studio enables the discovery and design of complex antibodies that include multispecific antibodies, imbalanced antibodies, serial internalizing antibodies, and catabodies. Using computer-aided antibody design (CAAD) platforms and traditional methods (hybridoma, phage display, and B-cell cloning) for rapid development, the company provides expertise in antibody design and optimization, which has led to promising clinical programs from both out-licensed assets and CRO projects.
